1. Home
  2. RVMDW vs SBSI Comparison

RVMDW vs SBSI Comparison

Compare RVMDW & SBSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVMDW
  • SBSI
  • Stock Information
  • Founded
  • RVMDW N/A
  • SBSI 1960
  • Country
  • RVMDW United States
  • SBSI United States
  • Employees
  • RVMDW 490
  • SBSI N/A
  • Industry
  • RVMDW
  • SBSI Major Banks
  • Sector
  • RVMDW
  • SBSI Finance
  • Exchange
  • RVMDW Nasdaq
  • SBSI Nasdaq
  • Market Cap
  • RVMDW N/A
  • SBSI N/A
  • IPO Year
  • RVMDW N/A
  • SBSI N/A
  • Fundamental
  • Price
  • RVMDW $0.38
  • SBSI $34.95
  • Analyst Decision
  • RVMDW
  • SBSI
  • Analyst Count
  • RVMDW 0
  • SBSI 0
  • Target Price
  • RVMDW N/A
  • SBSI N/A
  • AVG Volume (30 Days)
  • RVMDW N/A
  • SBSI 114.6K
  • Earning Date
  • RVMDW N/A
  • SBSI 10-24-2024
  • Dividend Yield
  • RVMDW N/A
  • SBSI 4.10%
  • EPS Growth
  • RVMDW N/A
  • SBSI N/A
  • EPS
  • RVMDW N/A
  • SBSI 2.78
  • Revenue
  • RVMDW N/A
  • SBSI $244,615,000.00
  • Revenue This Year
  • RVMDW N/A
  • SBSI N/A
  • Revenue Next Year
  • RVMDW N/A
  • SBSI $2.26
  • P/E Ratio
  • RVMDW N/A
  • SBSI $12.65
  • Revenue Growth
  • RVMDW N/A
  • SBSI N/A
  • 52 Week Low
  • RVMDW N/A
  • SBSI $25.30
  • 52 Week High
  • RVMDW N/A
  • SBSI $38.00
  • Technical
  • Relative Strength Index (RSI)
  • RVMDW N/A
  • SBSI 52.53
  • Support Level
  • RVMDW N/A
  • SBSI $35.16
  • Resistance Level
  • RVMDW N/A
  • SBSI $38.00
  • Average True Range (ATR)
  • RVMDW 0.00
  • SBSI 1.20
  • MACD
  • RVMDW 0.00
  • SBSI -0.05
  • Stochastic Oscillator
  • RVMDW 0.00
  • SBSI 50.49

About RVMDW Revolution Medicines Inc. Warrant

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio, and SOS1 and 4EBP1/mTORC1 programs.

Share on Social Networks: